A photo of Christopher Peltier.

Director, Community Section, Division of General and Community Pediatrics

Associate Professor, UC Department of Pediatrics

513-752-3650

513-752-3387

Board Certified

My Biography & Research

Biography

Dr. Christopher Peltier is an associate professor of Clinical Pediatrics and serves as the director of the Community Section in the Division of General and Community Pediatrics at Cincinnati Children’s Hospital Medical Center. His academic interests include community based pediatric education and faculty development, specializing in teaching educators how to give effective feedback to learners. As the director of the General Pediatrics Community Section, he is responsible for recruiting and retaining over 50 community preceptors to teach medical students from the University of Cincinnati College of Medicine and pediatric residents from Cincinnati Children’s Hospital Medical Center. He is the course director for both the Basic and National Faculty and Healthcare Educator Conferences at Cincinnati Children’s. Nationally, he is the co-chair of the Academic Pediatric Association’s Faculty Development Special Interest Group and was a co-founder of the Academic Pediatric Association’s Teaching in Community Settings Special Interest Group. He has given numerous workshops locally, regionally and nationally on teaching in the community setting, giving feedback to learners, and evaluation of learners. He has received the Cincinnati Children’s Outstanding Community Teacher award, the University of Cincinnati College of Medicine Outstanding Preceptor Award and the Cincinnati Children’s Faculty Educator Achievement Award.

Clinical Interests

Medical education

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Divisions

General and Community Pediatrics, General and Community Pediatrics

My Education

MD: University of Cincinnati, Cincinnati, OH, 1995.

Residency: Riley Hospital for Children, Indianapolis, IN, 1995-1998.

Chief Resident: Riley Hospital for Children, Indianapolis, IN, 1998-1999.

Certification: General Pediatrics, 1999.

My Publications

The Decline in Community Preceptor Teaching Activity: Exploring the Perspectives of Pediatricians Who No Longer Teach Medical Students. Paul, CR; Vercio, C; Tenney-Soeiro, R; Peltier, C; Ryan, MS; Van Opstal, ER; Alerte, A; Christy, C; Kantor, JL; Mills, WA; et al. Academic Medicine. 2020; 95:301-309.

A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration. Nan-Chang, C; Clifford, R; Li-Min, H; Yhu-Chering, H; Jo, DS; Kim, CS; Kim, HM; Kim, K; Kim, K; Kim, Y; et al. Human Vaccines and Immunotherapeutics. 2019; 15:786-799.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Greenberg, D; Hoover, PA; Vesikari, T; Peltier, C; Hurley, DC; McFetridge, RD; Dallas, M; Hartzel, J; Marchese, RD; Coller, BG; et al. Vaccine. 2018; 36:6883-6891.

Recruitment and Retention of Community Preceptors. Ryan, MS; Leggio, LE; Peltier, CB; Chatterjee, A; Arenberg, S; Byerley, JS; Belkowitz, JL; Rabalais, GP; Barone, MA. Pediatrics. 2018; 142:e20180673-e20180673.

Recruitment and Retention: Recommendations from the Association of Medical School Pediatric Department Chairs Education Committee and the Council on Medical Student Education in Pediatrics Task Force on Community Preceptors. Leggio, LE; Ryan, MS; Peltier, CB; Belkowitz, J; Barone, MA; Byerley, JS; Chatterjee, A; Nakamura, KT; Stirling, JM; Rabalais, GP. The Journal of Pediatrics. 2017; 191:4-5.e1.

Recruiting and Retaining Community-Based Preceptors: A Multicenter Qualitative Action Study of Pediatric Preceptors. Dallaghan, GL B; Alerte, AM; Ryan, MS; Patterson, PB; Petershack, J; Christy, C; Jr, MW A; Paul, CR; Peltier, C; Stamos, JK; et al. Academic Medicine. 2017; 92:1168-1174.

Two-year antibody persistence in children vaccinated at 12-15months with a measles-mumps-rubella virus vaccine without human serum albumin. Berry, AA; Abu-Elyazeed, R; Diaz-Perez, C; Mufson, MA; Harrison, CJ; Leonardi, M; Twiggs, JD; Peltier, C; Grogg, S; Carbayo, A; et al. Human Vaccines and Immunotherapeutics. 2017; 13:1516-1522.

A Randomized, Consistency Study Comparing Immunogenicity and Safety of 2 Vaccines Against Measles, Mumps and Rubella (MMR) Administered to Children 12–15 Months of Age. Henry, O; Klein, NP; Povey, M; Parra, MM; Diez-Domingo, J; Ahonen, A; Abu-Elyazeed, R; Korhonen, T; Tinoco, J; Weiner, L; et al. Open Forum Infectious Diseases. 2016; 3.